25785-10-8 Usage
General Description
Ethyl 5-amino-1-benzothiophene-2-carboxylate is a chemical compound with a molecular formula C12H13NO2S. It is a synthetic intermediate used in the pharmaceutical industry for the production of various drugs and organic compounds. ETHYL 5-AMINO-1-BENZOTHIOPHENE-2-CARBOXYLATE is a derivative of benzothiophene, which is a heterocyclic aromatic compound containing a sulfur atom in its ring structure. Ethyl 5-amino-1-benzothiophene-2-carboxylate has potential applications in drug discovery and development, particularly in the synthesis of novel therapeutics for various medical conditions. Its chemical structure and properties make it a valuable building block for the creation of complex organic molecules with potential pharmaceutical applications.
Check Digit Verification of cas no
The CAS Registry Mumber 25785-10-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,5,7,8 and 5 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 25785-10:
(7*2)+(6*5)+(5*7)+(4*8)+(3*5)+(2*1)+(1*0)=128
128 % 10 = 8
So 25785-10-8 is a valid CAS Registry Number.
InChI:InChI=1/C11H11NO2S/c1-2-14-11(13)10-6-7-5-8(12)3-4-9(7)15-10/h3-6H,2,12H2,1H3
25785-10-8Relevant articles and documents
Benzo[b]thiophene-based histone deacetylase inhibitors
Witter, David J.,Belvedere, Sandro,Chen, Liqiang,Secrist, J. Paul,Mosley, Ralph T.,Miller, Thomas A.
, p. 4562 - 4567 (2008/02/11)
Benzo[b]thienyl hydroxamic acids, a novel class of histone deacetylase (HDAC) inhibitors, were identified via a targeted screen of small molecule hydroxamic acids. Various substitutions were explored in the C5- and C6-positions of the benzo[b]thiophene co
Inhibitors of soluble adenylate cyclase
-
Page/Page column 7-8, (2008/06/13)
The invention relates to compounds of general Formula I, the production thereof, and the use thereof as a medicinal product.
BENZOTHIOPHENE HYDROXAMIC ACID DERIVATIVES WITH CARBAMATE, UREA, AMIDE AND SULFONAMIDE SUBSTITUTIONS
-
Page/Page column 44, (2008/06/13)
The present invention relates to a novel class of hydroxamic acid derivatives carbamate, urea, amide and sulfonamide substitutions. The hydroxamic acid compounds can be used to treat cancer. The hydroxamic acid compounds can also inhibit histone deacetyla